Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Nanoparticle Formulation : SOP for Optimization of Particle Size in Nanoparticle Formulations

Posted on By

SOP for Optimization of Particle Size in Nanoparticle Formulations

Standard Operating Procedure for Optimization of Particle Size in Nanoparticle Formulations

1) Purpose

This SOP outlines the process for optimizing the particle size of nanoparticle formulations. Particle size is a critical parameter in determining drug release rate, biodistribution, and therapeutic efficacy.

2) Scope

This SOP applies to personnel involved in adjusting and optimizing the particle size of nanoparticles for pharmaceutical or industrial applications.

3) Responsibilities

  • Operators: Responsible for optimizing particle size during nanoparticle preparation as per this SOP.
  • QA: Ensures that the particle size of the final formulations meets required specifications.
See also  Nanoparticle Formulation : SOP for Preparation of Metal Nanoparticles

4) Procedure

4.1 Selection of Methods

4.1.1 Method Selection

  • 4.1.1.1 Choose an appropriate method to control particle size, such as high-pressure homogenization, ultrasonication, or microfluidization, depending on the desired size range.

4.2 Particle Size Reduction

4.2.1 Homogenization

  • 4.2.1.1 Use high-pressure homogenization to reduce particle size to the nanoscale by applying shear forces to the nanoparticle suspension.

4.2.2 Ultrasonication

  • 4.2.2.1 Apply ultrasonic waves to the suspension to break down larger particles and achieve the desired nanoscale dimensions.

4.3 Particle Size Measurement

4.3.1 Dynamic Light Scattering (DLS)

  • 4.3.1.1 Measure the particle size at different stages of the formulation process using DLS to monitor size distribution and optimize the process parameters.
See also  Nanoparticle Formulation : SOP for Use of Cryoprotectants in Nanoparticle Formulations

4.4 Stability Testing

4.4.1 Stability Assay

  • 4.4.1.1 Perform stability tests to confirm that the optimized
nanoparticles maintain their size over time without aggregation or degradation.

4.5 Storage

4.5.1 Storage Conditions

  • 4.5.1.1 Store the optimized nanoparticle formulations at 4°C in sealed, sterile containers to maintain stability.

5) Abbreviations, if any

  • DLS: Dynamic Light Scattering

6) Documents, if any

  • Particle Size Optimization Logbook

7) References, if any

  • Guidelines for particle size optimization in nanoparticle formulations

8) SOP Version

Version 1.0

Annexure

Particle Size Optimization Logbook Template

Date Batch Number Method Used Particle Size Stability Results Operator Initials QA Initials
DD/MM/YYYY Batch Number Method Used Size in nm Pass/Fail Operator Name QA Name
           
See also  SOP for Supercritical Fluid Techniques for Nanoparticle Preparation
Nanoparticle Formulation Tags:Nanoparticle biomedical applications SOP, Nanoparticle clinical trial SOP, Nanoparticle encapsulation SOP, Nanoparticle formulation SOP, Nanoparticle handling SOP, Nanoparticle preparation procedure, Nanoparticle production SOP, Nanoparticle quality control SOP, Nanoparticle size optimization SOP, Nanoparticle SOP, Nanoparticle stability testing SOP, Nanoparticle standard operating procedures, Nanoparticle sterilization SOP, Nanoparticle storage SOP, Nanoparticle surface modification SOP, Nanoparticle synthesis SOP, Nanoparticle toxicology SOP, SOP for nanomaterials, SOP for nanoparticle characterization, SOP for nanoparticle drug delivery, SOP for nanoparticle gene delivery, SOP for nanoparticle regulatory compliance, SOP for nanoparticle safety, SOP for nanoparticle scaling, SOP for targeted drug delivery nanoparticles

Post navigation

Previous Post: SOP for Preparation of Oil-in-Water (O/W) Emulsions
Next Post: SOP for Preparation of Nasal Sprays for Targeted Brain Delivery

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version